Cargando…

Brain Metabolic Alterations in Alzheimer’s Disease

The brain is one of the most energy-consuming organs in the body. Satisfying such energy demand requires compartmentalized, cell-specific metabolic processes, known to be complementary and intimately coupled. Thus, the brain relies on thoroughly orchestrated energy-obtaining agents, processes and mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ardanaz, Carlos G., Ramírez, María J., Solas, Maite
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998942/
https://www.ncbi.nlm.nih.gov/pubmed/35409145
http://dx.doi.org/10.3390/ijms23073785
_version_ 1784685064092647424
author Ardanaz, Carlos G.
Ramírez, María J.
Solas, Maite
author_facet Ardanaz, Carlos G.
Ramírez, María J.
Solas, Maite
author_sort Ardanaz, Carlos G.
collection PubMed
description The brain is one of the most energy-consuming organs in the body. Satisfying such energy demand requires compartmentalized, cell-specific metabolic processes, known to be complementary and intimately coupled. Thus, the brain relies on thoroughly orchestrated energy-obtaining agents, processes and molecular features, such as the neurovascular unit, the astrocyte–neuron metabolic coupling, and the cellular distribution of energy substrate transporters. Importantly, early features of the aging process are determined by the progressive perturbation of certain processes responsible for adequate brain energy supply, resulting in brain hypometabolism. These age-related brain energy alterations are further worsened during the prodromal stages of neurodegenerative diseases, namely Alzheimer’s disease (AD), preceding the onset of clinical symptoms, and are anatomically and functionally associated with the loss of cognitive abilities. Here, we focus on concrete neuroenergetic features such as the brain’s fueling by glucose and lactate, the transporters and vascular system guaranteeing its supply, and the metabolic interactions between astrocytes and neurons, and on its neurodegenerative-related disruption. We sought to review the principles underlying the metabolic dimension of healthy and AD brains, and suggest that the integration of these concepts in the preventive, diagnostic and treatment strategies for AD is key to improving the precision of these interventions.
format Online
Article
Text
id pubmed-8998942
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89989422022-04-12 Brain Metabolic Alterations in Alzheimer’s Disease Ardanaz, Carlos G. Ramírez, María J. Solas, Maite Int J Mol Sci Review The brain is one of the most energy-consuming organs in the body. Satisfying such energy demand requires compartmentalized, cell-specific metabolic processes, known to be complementary and intimately coupled. Thus, the brain relies on thoroughly orchestrated energy-obtaining agents, processes and molecular features, such as the neurovascular unit, the astrocyte–neuron metabolic coupling, and the cellular distribution of energy substrate transporters. Importantly, early features of the aging process are determined by the progressive perturbation of certain processes responsible for adequate brain energy supply, resulting in brain hypometabolism. These age-related brain energy alterations are further worsened during the prodromal stages of neurodegenerative diseases, namely Alzheimer’s disease (AD), preceding the onset of clinical symptoms, and are anatomically and functionally associated with the loss of cognitive abilities. Here, we focus on concrete neuroenergetic features such as the brain’s fueling by glucose and lactate, the transporters and vascular system guaranteeing its supply, and the metabolic interactions between astrocytes and neurons, and on its neurodegenerative-related disruption. We sought to review the principles underlying the metabolic dimension of healthy and AD brains, and suggest that the integration of these concepts in the preventive, diagnostic and treatment strategies for AD is key to improving the precision of these interventions. MDPI 2022-03-29 /pmc/articles/PMC8998942/ /pubmed/35409145 http://dx.doi.org/10.3390/ijms23073785 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ardanaz, Carlos G.
Ramírez, María J.
Solas, Maite
Brain Metabolic Alterations in Alzheimer’s Disease
title Brain Metabolic Alterations in Alzheimer’s Disease
title_full Brain Metabolic Alterations in Alzheimer’s Disease
title_fullStr Brain Metabolic Alterations in Alzheimer’s Disease
title_full_unstemmed Brain Metabolic Alterations in Alzheimer’s Disease
title_short Brain Metabolic Alterations in Alzheimer’s Disease
title_sort brain metabolic alterations in alzheimer’s disease
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998942/
https://www.ncbi.nlm.nih.gov/pubmed/35409145
http://dx.doi.org/10.3390/ijms23073785
work_keys_str_mv AT ardanazcarlosg brainmetabolicalterationsinalzheimersdisease
AT ramirezmariaj brainmetabolicalterationsinalzheimersdisease
AT solasmaite brainmetabolicalterationsinalzheimersdisease